Cerebras Files to IPO as Nvidia's Biggest Passive Holder Quietly Cut More Than a Billion Shares
Cerebras Systems filed its US IPO paperwork just as the most important institutional signal on Nvidia flipped bearish: Vanguard, which held 9.32% of NVDA (2.27 billion shares) in late January 2026, filed a Schedule 13G/A in March showing ownership had dropped below the 5% reporting threshold. That's a reduction of at least 1.05 billion shares in two months — the single largest mega-cap position unwind visible in our 13D/G data — and it happened just before a credible AI-chip rival filed to go public.
Nvidia (NVDA) has spent the last two years as the most crowded long in institutional finance — the clearing mechanism for virtually every AI investment thesis on Wall Street. That unanimous ownership structure is now shifting. Cerebras Systems, the wafer-scale AI-chip competitor that has raised north of $700 million privately, filed its US IPO paperwork this week. And according to 13D/G filings tracked on 13F Insight, the single most consequential shift in NVDA's institutional ownership didn't come from hedge funds or activists — it came from Vanguard, and it happened quietly over the eight weeks leading up to the Cerebras news.
The 13G Signal That Matters: Vanguard's 1+ Billion Share Reduction
On January 30, 2026, Vanguard filed a Schedule 13G/A disclosing ownership of 2,266,625,855 shares of NVDA — a 9.32% stake. Vanguard files 13G amendments whenever its percentage ownership crosses a reporting threshold. At 9.32%, it was within 68 basis points of the 10% threshold that would trigger a higher-scrutiny passive-holder classification.
On March 26, 2026 — just eight weeks later — Vanguard filed a fresh 13G/A disclosing ownership had fallen below the 5% reporting threshold entirely. That is a reduction of at least 4.32 percentage points, or approximately 1.05 billion shares, in two months. On Nvidia's float, that is roughly $200+ billion in dollar flow assuming an average sale price near the stock's Q1 2026 range.
| Filing Date | Form | Filer | % Owned | Shares |
|---|---|---|---|---|
| 2026-03-26 | SCHEDULE 13G/A | Vanguard Group | <5% (below threshold) | — reduction from prior ~2.27B |
| 2026-01-30 | SCHEDULE 13G/A | Vanguard Group | 9.320% | 2,266,625,855 |
| 2024-11-12 | SC 13G/A | FMR LLC (Fidelity) | 4.069% | Below-threshold |
| 2024-02-09 | SC 13G/A | FMR LLC (Fidelity) | 5.176% | Above-threshold |
| 2024-01-26 | SC 13G/A | BlackRock Finance | 7.300% | Above-threshold |
For context: Vanguard's passive index obligation — its S&P 500 and Russell 3000 exposure — would normally force it to maintain proportional weight in a stock as heavily benchmarked as NVDA. A sub-5% filing from Vanguard on a company of this size is not a minor rebalance. It implies either active-sleeve repositioning across Vanguard's quasi-index products, a migration to different share classes that consolidate under a different reporting entity, or deliberate reduction of aggregate exposure. In any scenario, it is the most meaningful institutional signal NVDA has received since the AI bubble debate began.
What Cerebras Means for the AI Chip Economics
Cerebras Systems manufactures wafer-scale integrated AI accelerators — chips that are literally the size of a dinner plate, containing 900,000+ cores on a single piece of silicon. Its value proposition against Nvidia's GPU architecture is architectural specialization: for training very large models, Cerebras claims lower latency and dramatically reduced system-level complexity versus Nvidia's HGX platforms.
Historically, Cerebras's market penetration has been limited by capital constraints — wafer-scale fabrication is capex-intensive and its $700M+ of private capital was insufficient for the foundry and data-center buildout required to compete at hyperscaler scale. The IPO changes that. If Cerebras can raise $1-3 billion in public equity plus access debt markets, it gains the first real shot at establishing a second-source option for AI training workloads.
Separately reported, OpenAI is now discussed as a potential $20 billion committed customer for Cerebras chips — the first hyperscaler-scale anchor that validates the Cerebras thesis. If that deal materializes with Cerebras as a publicly capitalized competitor, Nvidia's pricing power on its highest-margin H100/B100 product line comes under direct pressure for the first time since 2023.
What the 13G Silence Tells Us
Equally informative is what has NOT been filed. We have seen no recent Schedule 13D activist filings on NVDA, no new FMR or BlackRock-level 13G amendments, and no material Form 4 insider buying in the 90 days before the Cerebras IPO news. The institutional signal is dominated by a single data point: Vanguard quietly shrinking the largest passive stake in the company.
That silence from other mega-holders suggests the Vanguard move is not yet being matched by BlackRock, Fidelity, State Street, or Geode Capital Management (Fidelity's index subsidiary). Whether that is divergence (other indexers remaining at full weight as Vanguard repositions) or lag (they will follow in the next quarterly update) is the key near-term question. The absence of reciprocal moves from Morgan Stanley — another top-10 holder of NVDA — is particularly notable, since its active advisory business would typically move in the direction of the thesis shift, not against it.
Market Context: AI Chip Competition Enters a New Phase
Nvidia shares have been the benchmark for AI exposure across virtually every institutional portfolio. The stock's correlation with the entire AI narrative has meant that institutional risk-off in AI — whether driven by capex moderation signals at hyperscalers, antitrust scrutiny of the GPU supply chain, or the emergence of credible alternatives — shows up in NVDA first.
Cerebras going public is a discrete structural event in the second category. It's not a thesis-breaking development on its own — Nvidia's 18-month technology lead is real — but it marks the first time a pure-play AI chip competitor will have public-market access to capital at scale. For a stock whose valuation partially reflects the assumption of limited competition, that matters.
What to Watch
- Q1 2026 13F filings (due May 15, 2026): Vanguard's formal 13F will show the quarter-end share count. If the post-threshold number is materially below the ~1.05 billion implied by the 13G/A, it confirms the reduction was active, not mechanical.
- BlackRock 13G update: BlackRock's last visible 13G on NVDA is dated January 2024 at 7.3%. A 2026 refresh would be the second-most-important single data point after Vanguard's move.
- Cerebras S-1 specifics: Expected revenue run rate, customer concentration (especially OpenAI disclosure), and chip roadmap versus Nvidia's B100/B200 release schedule. The valuation target on the S-1 will signal how aggressively Cerebras plans to price.
- Form 4 insider activity: Insider purchases from Nvidia executives or directors in the next 60 days would be a meaningful counter-signal to the Vanguard reduction.
- OpenAI–Cerebras commercial terms: The reported $20 billion commitment needs specific disclosure — volume commitments, delivery schedule, exclusivity. Any of those would materially shift the GPU demand model that supports NVDA's forward estimates.
Key Facts
- Primary Ticker: NVDA (Nvidia Corp)
- Event Type: Other — AI chip competitive structure shift
- Most Important Data Point: Vanguard's reduction from 9.32% (Jan 2026) to sub-5% (Mar 2026) — at least 1.05 billion shares unwound
- Secondary Signal: FMR LLC (Fidelity) dropped from 5.18% (Feb 2024) to 4.07% (Nov 2024) and has not refiled, suggesting sustained sub-threshold position
- Recent Insider Sentiment: Neutral — no meaningful Form 4 buys in 90 days before Cerebras news
- Related Event: Cerebras Systems filed US IPO paperwork, first public AI-chip competitor with scaled capital access
Track NVDA's full institutional ownership history → or monitor Vanguard's complete tech-sector portfolio on 13F Insight.
Related Research
Explore all researchVictory Capital kept mega-cap tech on top in Q4 2025, but the sharper signal was in the secondary moves: large increases in Netflix, Constellation Energy, TSMC and new positions like IQVIA. The next filing will show whether that diversification continues.
Apr 17, 2026
Fisher’s Q4 2025 filing was still packed with mega-cap tech, but the bigger tell was a giant Treasury and investment-grade corporate bond sleeve built through IEF and VCIT. The next filing will show whether that duration bet was tactical or structural.
Apr 17, 2026
CalPERS used Q4 2025 to keep broad-market exposure high through VOO while still adding to Nvidia, Microsoft, Alphabet and Broadcom. The next filing will show whether the pension giant keeps that simple beta-heavy structure or rotates again.
Apr 17, 2026
AllianceBernstein kept Nvidia, Microsoft and Amazon on top in Q4 2025, but new exposure to Intuitive Surgical and aggressive increases in Netflix and ServiceNow made the next filing more interesting than another mega-cap recap. Here is what to watch.
Apr 17, 2026
Principal’s Q4 2025 filing looked slightly weaker on headline AUM, but the internal rotation was more revealing: Brookfield became a top-ten position, Netflix surged, and the fund cut back in parts of real estate. The next filing will show whether that shift keeps going.
Apr 17, 2026